8 completed. 7 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 1 | Completed 1 |
Follow vestipitant: new trials by email Literature Review of vestipitant trials Research Report on vestipitant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV) Ondansetron, Vestipitant - Postoperative Nausea and Vomiting | Phase 2 | Completed | Accenture | 131 | 2012-02-01 | 2012-10-02 |
| Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV) GW597599, Placebo - Post-Operative Nausea and Vomiting (PONV) | Phase 1 | Completed | Accenture | 55 | 2011-05-01 | 2011-10-13 |
| Vestipitant 28-day Tolerance Study GW597599, Placebo - Sleep Disorders | Phase 2 | Completed | GlaxoSmithKline | 161 | 2009-05-01 | 2016-10-28 |
| A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia GR205171, GW597599 - Sleep Initiation and Maintenance Disorders | Phase 2 | Completed | GlaxoSmithKline | 51 | 2007-12-19 | 2017-07-11 |
| Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss. Vestipitant, Vestipitant + Paroxetine, Placebo - Tinnitus | Phase 2 | Completed | GlaxoSmithKline | 26 | 2006-12-01 | 2016-10-28 |
| Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients GW597599 - Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative | Phase 2 | Completed | GlaxoSmithKline | 624 | 2004-12-01 | 2017-01-20 |
| A Combination Therapy In Patients With Social Anxiety Disorder vestipitant/paroxetine - Social Phobia | Phase 2 | Completed | GlaxoSmithKline | 204 | 2004-11-01 | 2016-09-15 |
| PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients vestipitant, paroxetine - Depressive Disorder and Anxiety Disorders | Phase 2 | Completed | GlaxoSmithKline | 72 | 2004-11-01 | 2016-09-15 |
Anxiety Disorders (2) · Phobia, Social (2) · Postoperative Nausea and Vomiting (2) · Sleep Initiation and Maintenance Disorders (2) · Vomiting (2) · Depressive Disorder (1) · Hearing Loss (1) · Sleep Wake Disorders (1) · Tinnitus (1)
GlaxoSmithKline (6) · Accenture (2)
Germany (3) · Australia (2) · South Africa (2) · United Kingdom (2) · United States (2) · Belgium (1) · Canada (1) · Chile (1) · Czechia (1) · Denmark (1) · Finland (1) · Netherlands (1) · Norway (1) · Poland (1) · Sweden (1)
Richard A Brigandi, MD, PhD (1)